Combination of STAT inhibitors and immune checkpoint inhibitors for the treatment and / or management of cancer
JP2025509178A5Pending Publication Date: 2026-03-11TVARDI THERAPEUTICS INC
0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-03-03
- Publication Date
- 2026-03-11
Smart Images
Figure 00000000_0000_ABST
Abstract
Provided herein are methods of treating cancer in a subject in need thereof, the methods comprising administering to the subject an effective amount of a STAT inhibitor and an effective amount of an immune checkpoint inhibitor (e.g., a PD-1 inhibitor or a PD-L1 inhibitor).
Need to check novelty before this filing date? Find Prior Art